+92-335-2115333

Mon to Sun 9:00 am to 12:00 am

Karachi, Pakistan

  • Verify Certificate   |
  • Registration
  • Login

    • ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% - Fierce Pharma Detail

    • Home
    • ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% - Fierce Pharma Detail
    ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% - Fierce Pharma

    ASCO: Akeso’s ivonescimab bests PD-1 inhibitor in lung cancer chemo combos, slashing death risk by 34% - Fierce Pharma

    By Angus Liu | Published: May 31, 2026

    No additional content available.

    Read Full Article
    whatsapp
    SCROLL TO TOP